InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Burrows Scott L, Chief Financial Officer. Insider active across 2 companies, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 26 reports have been recorded. Breakdown: 0 buy · 16 sells. Total volume traded: €2.7m. Activity tracked since 27 December 2021. The latest transaction was filed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Burrows Scott L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
7,500 shares@ US$14.500.0013% mcap3.3% of flowCommon StockSEC:0001636282-26-000100:0
5,100 shares@ US$95.210.0059% mcap14.6% of flowCommon StockSEC:0001636282-26-000100:1
2,300 shares@ US$96.300.0027% mcap6.7% of flowCommon StockSEC:0001636282-26-000100:2
100 shares@ US$97.100.0001% mcap0.3% of flowCommon StockSEC:0001636282-26-000100:3
10,000 sharesCommon StockSEC:0001853327-26-000008:2
15,000 sharesCommon StockSEC:0001853327-26-000008:0
5,000 sharesCommon StockSEC:0001853327-26-000008:1
7,500 shares@ US$14.5016.9% of flowCommon StockSEC:0001636282-26-000076:0
1,801 shares@ US$69.7519.6% of flowCommon StockSEC:0001636282-26-000076:1
2,599 shares@ US$70.7728.7% of flowCommon StockSEC:0001636282-26-000076:2
3,100 shares@ US$72.0634.8% of flowCommon StockSEC:0001636282-26-000076:3
12,500 shares@ US$14.500.0023% mcap10.5% of flowCommon StockSEC:0001853327-26-000005:0
12,500 shares@ US$71.370.011% mcap51.8% of flowCommon StockSEC:0001853327-26-000005:1
7,500 shares@ US$14.505.0% of flowCommon StockSEC:0001853327-26-000003:0
1,300 shares@ US$49.983.0% of flowCommon StockSEC:0001853327-26-000003:2
6,200 shares@ US$49.2114.0% of flowCommon StockSEC:0001853327-26-000003:1
2,500 shares@ US$14.501.4% of flowCommon StockSEC:0001636282-26-000028:0
18,428 shares@ US$16.2612.0% of flowCommon StockSEC:0001636282-25-000095:0
134,953 shares0Common StockSEC:0000950170-23-072763:0
291 shares@ US$15.26340.9% of flowCommon StockSEC:0001567619-23-004671:0
21,000 shares0Common StockSEC:0001567619-23-004547:0
416 shares@ US$16.16631.3% of flowCommon StockSEC:0001567619-23-004270:0
5,000 shares@ US$1.68061.8% of flowCommon StockSEC:0001567619-22-017633:0
13,300 shares0Common StockSEC:0001567619-22-006494:0
420 shares@ US$17.75272.7% of flowCommon StockSEC:0001567619-22-006228:0
25 of 26 declarations
About Burrows Scott L
Burrows Scott L is Chief Financial Officer at Spyre Therapeutics, Inc. and Arcutis Biotherapeutics, Inc. He has 22 filings in total, and across the 22 sampled filings, the transactions are all sales for EUR 2036087, between 2021-12-28 and 2026-06-26.
